QA: Unicycive Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001766140_2026_Unicycive_Therapeutics_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001766140, Unicycive Therapeutics Inc

  xvar xval
0 AssetsCurrent 48,961,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 66,000
3 remainder_Assets 108,000
4 LiabilitiesCurrent 18,938,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 44,923,382
9 ResearchAndDevelopmentExpense 11,851,671
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,322,940
13 remainder_ComprehensiveNetIncome -1,000
  yvar yval
0 Assets 49,135,000
1 Liabilities 18,938,000
2 Expenses 56,775,053
3 Revenues 0
4 StockholdersEquity 30,197,000
5 NetIncome -54,452,113
6 ComprehensiveNetIncome -54,452,613
7 BaseVar 63,585,996
8 EconomicCapitalRatiobeforeLimitedLiability 0.334
9 EconomicCapitalRatio 1.73

Edgar->Model Mapping

Feature Distribution

Change over Time